Virus News and Research

Latest Virus News and Research

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

Nine months into the global pandemic, which has infected more than 32 million people, there is still no approved effective and safe drug or vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

24 Sep 2020

Linoleic acid binds SARS-CoV-2 spike protein

Now, a team of researchers at the Max Planck-Bristol Center for Minimal Biology and Bristol's School of Biochemistry has identified a druggable pocket in the virus's spike protein that can be used to prevent the infection of cells. The study findings, published in the journal Science, are a groundbreaking discovery that will help develop new therapies and drugs to stem the growing pandemic.

24 Sep 2020

School re-openings in US may increase COVID-19 spread unless targeted interventions are in place

In a new study published on the preprint server medRxiv, a team of researchers on behalf of the Imperial College London COVID-19 Response Team used longitudinal and age-specific population mobility and COVID-19 mortality data to model and predict SARS-CoV-2 spread in the US.

24 Sep 2020

Cold plasma inactivates SARS-CoV-2

In one such effort, Zhitong Chen et al., in a recent medRxiv* preprint paper find that by employing an efficient cold atmospheric plasma (CAP) with argon feed gas on different surfaces inactivates the infectious SARS-CoV-2 virus.

24 Sep 2020

Genetic variation not linked with differences in COVID-19 morbidity and mortality

A comprehensive search of genetic variation databases has revealed no significant differences across populations and ethnic groups in seven genes associated with viral entry of SARS-CoV-2.

24 Sep 2020

Cellular and molecular map of the human heart could guide personalized medicine

Scientists have created a cellular and molecular map of the healthy human heart, to understand how this vital organ functions, and to shed light on what goes wrong in cardiovascular disease.

24 Sep 2020

Federal restrictions on corneal donations prevent vision-restoring surgery

Some forms of blindness and visual impairment can be cured with a corneal transplant surgery using donated eye tissue. However, federal regulations in the United States and Canada severely restrict the ability of sexually active gay and bisexual men from donating their eye tissue.

24 Sep 2020

Researchers uncover a new parvovirus strategy for reaching the cell nucleus

Researchers at the Institut national de la recherche scientifique (INRS), in collaboration with American scientists, have uncovered a new parvovirus strategy for reaching the cell nucleus which is their site of replication.

24 Sep 2020

Molecular analysis of COVID-19's second wave shows mutant viruses linked to rapid spread

Molecular analysis of COVID-19's powerful second wave in Houston – from May 12 to July 7 – shows a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston's first wave.

24 Sep 2020

AI used to define the cytokine storm implicated in fatal COVID-19

A new study published on the preprint server bioRxiv* in September 2020 reports the use of artificial intelligence (AI) to identify an invariant or universal host immune response found in all viral pandemics so far. The association of this response with severe COVID-19 phenotypes indicates a new understanding of the human immune response in viral pandemics.

24 Sep 2020

Research says in SARS-CoV-2 canine infection, transmission unlikely

A new study published on the preprint server bioRxiv* in September 2020 shows that pet dogs have been falling sick and dying of a mysterious respiratory infection, often showing the presence of anti- severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, even though in many cases they do not test positive for COVID-19.

24 Sep 2020

New initiative launched to combat the spread of disinformation on COVID-19

The Coronavirus disease (COVID-19) is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected.

24 Sep 2020

Molecular insights may foster effective therapies for COVID-19 patients

Viral and bacterial pathogens wield pathogenic or virulent proteins that interact with high-value targets inside human cells, attacking what is known as the host interactome. The host interactome is the network map of all the protein-protein interactions inside cells.

24 Sep 2020

Aerosol-based study of COVID-19 risk indoors, and the impact of preventive measures

A recent study describes the estimated risk of COVID-19 transmission via aerosols in many different situations, as well as the expected reduction in risk associated with the use of various preventive measures.

24 Sep 2020

Brazil becomes global hotspot for COVID-19 pandemic

Two nationwide COVID-19 antibody seroprevalence studies from Brazil show that many cities along the Amazon were hit hardest at the beginning of the epidemic in May and June, along with poorer and Indigenous communities.

24 Sep 2020

FDA issues emergency use authorization for first serology point-of-care test for COVID-19

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.

24 Sep 2020

Many people are overestimating their risk of becoming seriously ill and dying from COVID-19

A new National Science Foundation-funded survey of six states has found that during the past two months, more people are wearing masks, vaccine uncertainty is on the rise, and many people are overestimating their risk of becoming seriously ill and dying from COVID-19.

24 Sep 2020

Study: R-spondin growth factor reduces intestinal tumors in early phase of colorectal cancer

Colorectal cancer constitute the third most common cancer in the Western world. Their incidence constantly increases as the population ages, and despite recent advances in colorectal cancer therapy, the cancer metastasizes in every third of colorectal cancer patients, and a significant part of these patients eventually die from the disease

24 Sep 2020

Researchers uncover an active role of glycans in SARS-CoV-2 spike protein

As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry.

24 Sep 2020

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

Researchers recently described a set of 11 Nbs derived from an immunized alpaca which showed high-affinity binding to the glycosylated SARS-CoV-2 spike receptor domain (RBD) in a study published in the preprint server bioRxiv.

23 Sep 2020

Virus News and Research

Latest Virus News and Research

Experimental cancer drug AR-12 inhibits SARS-CoV-2 virus

Linoleic acid binds SARS-CoV-2 spike protein

School re-openings in US may increase COVID-19 spread unless targeted interventions are in place

Cold plasma inactivates SARS-CoV-2

Genetic variation not linked with differences in COVID-19 morbidity and mortality

Cellular and molecular map of the human heart could guide personalized medicine

Federal restrictions on corneal donations prevent vision-restoring surgery

Researchers uncover a new parvovirus strategy for reaching the cell nucleus

Molecular analysis of COVID-19's second wave shows mutant viruses linked to rapid spread

AI used to define the cytokine storm implicated in fatal COVID-19

Research says in SARS-CoV-2 canine infection, transmission unlikely

New initiative launched to combat the spread of disinformation on COVID-19

Molecular insights may foster effective therapies for COVID-19 patients

Aerosol-based study of COVID-19 risk indoors, and the impact of preventive measures

Brazil becomes global hotspot for COVID-19 pandemic

FDA issues emergency use authorization for first serology point-of-care test for COVID-19

Many people are overestimating their risk of becoming seriously ill and dying from COVID-19

Study: R-spondin growth factor reduces intestinal tumors in early phase of colorectal cancer

Researchers uncover an active role of glycans in SARS-CoV-2 spike protein

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in